Business

Devonian Reports Results of its Annual General and Special Meeting of Shareholders

Not for distribution to United States newswire services or for dissemination in the United States...

articleDevonian Health Group, Inc.March 24, 20254/company/devonian-health-group-inc/news/devonian-reports-results-of-its-annual-general-and-special-meeting-of-shareholders
Devonian Reports Results of its Annual General and Special Meeting of Shareholders

About this update from Devonian Health Group, Inc.

[{"type":"text","content":"Devonian Reports Results of its Annual General and Special Meeting of Shareholders\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n\n\n Not for distribution to United States newswire services or for dissemination in the United States\n \n\n\n\n\n\n Devonian Health Group Inc. (“\n \n Devonian\n \n ” or the “\n \n Corporation\n \n ”) (\n \n TSXV: GSD; OTCQB: DVHGF\n \n ), a clinical stage corporation focused on developing unique solutions to inflammatory diseases held its annual general and special meeting of shareholders on March 20, 2025 (the “\n \n Meeting\n \n ”) online via live webcast. The Corporation reported that shareholders voted on, and approved, the following proposals at the Meeting.\n \n\n\n Election of Directors\n \n\n\n Taking into account the proxies received and the votes cast at the Meeting, the following individuals have been elected as directors of the Corporation until the next annual shareholders’ meeting: André P. Boulet, Louis Flamand, Luc Grégoire, Jean Forcione, Edward Dahl, David Charles Baker, Kathryn J. Gregory, and Dennis Turpin.\n \n\n\n Appointment of Auditors\n \n\n\n Taking into account the proxies received and the votes cast at the Meeting, MNP LLP has been appointed as the independent auditor of the Corporation for the current fiscal year ending July 31, 2025, and the directors of the Corporation have been authorized to determine its remuneration.\n \n\n\n Option Plan Amendment\n \n\n\n Under the TSX Venture Exchange (the “\n \n Exchange\n \n ”) policies, the stock option plan of the Corporation (the “\n \n Option Plan\n \n ”) is a “fixed up to 20%” plan, and any amendments must be approved by disinterested shareholders at a general meeting of the Corporation. The amendment aimed to increase the number of common shares in the capital of the Corporation (the “\n \n Shares\n \n ”) reserved for issuance under the Option Plan, so that it would represent 20% of the issued and outstanding Shares. At the Meeting, disinterested shareholders approved the amendment to the Option Plan.\n \n\n The full text of the Option Plan can be found in Schedule C of the Corporation's management and information circular, a copy of which can be found on the Corporation's SEDAR...

More updates from Devonian Health Group, Inc.